| Previous Section | Back to Table of Contents | Lords Hansard Home Page |
Baroness Quin asked Her Majestys Government:
What is the estimated cost of introducing individual electronic identification of sheep in (a) Northumberland, (b) England, and (c) the United Kingdom. [HL4997]
The Minister of State, Department for Environment, Food and Rural Affairs (Lord Rooker): There is no specific assessment for Northumberland. A draft partial regulatory impact assessment for England on sheep and goat electronic identification was produced in December 2006 and further updated in November 2007. Details are available on the Defra website.
Baroness Quin asked Her Majestys Government:
What discussions have been held recently within the European Union about individual electronic identification of sheep. [HL4998]
Lord Rooker: The European Parliament discussed electronic identification of sheep on 19 June as part of its wider discussions on the sheep industry. Discussions were also held on 30 June in the Commissions Standing Committee on the Food Chain and Animal Health (SCoFCAH).
The discussions held on 30 June were those that secured changes to the annexes of EC regulation 21/2004 which considerably reduce the movement-recording burdens for industry. The regulation now provides for a phased approach to the introduction of individual recording as follows:
no animals to have to be individually recorded on a movement document until 1 January 2011;no animals born before 31 December 2009 have to be individually recorded on a movement document until 31 December 2011; andno animal born before 31 December 2009 and moving to slaughter (directly or via a market) have to be individually recorded on a movement document at all.Baroness Quin asked Her Majestys Government:
What discussions have been held recently between Ministers and National Farmers Union representatives about European Union proposals on individual electronic identification of sheep. [HL4999]
Lord Rooker: My right honourable friend the Secretary of State (Hilary Benn) and I met representatives of the sheep industry, including the NFU, on 30 June to discuss electronic identification of sheep.
Lord Taylor of Holbeach asked Her Majestys Government:
Further to the reply by Lord Rooker on 7 July (Official Report, col. 573), why the earliest projected date for widespread use of a BCG cattle vaccine is mid to late 2015, in the light of the fact that human BCG has been available for 50 years. [HL4881]
The Minister of State, Department for Environment, Food and Rural Affairs (Lord Rooker): Vaccines based on BCG have variable efficacy and, because they will potentially make cattle react to the current tuberculin test as if they were infected with Mycobacterium bovis (M. bovis), are illegal under EU legislation. Without a test to differentiate infected from vaccinated animals (a so-called DIVA test), cattle from vaccinated herds would be indistinguishable from infected animals and would lose their officially tuberculosis free (OTF) status. When work started on vaccines in 1998, following recommendations made in the Krebs report (1997), it was expected that a non-BCG vaccine would be a candidate and research was conducted in parallel with human vaccine work. However, suitable non-BCG candidates have not been forthcoming for cattle or humans and, from 2005, work effort was concentrated on the identification of suitable antigens/adjuvants to improve the efficacy of BCG, which largely depended on the sequencing of the M. bovis and BCG genomes in 2001, and the development of a DIVA test.
Research by its nature takes time. This is compounded by the fact that bTB is a slow-moving disease and animal experiments take a long time to complete. To date no suitable antigen/adjuvant candidates have been identified. Therefore, we are progressing the work necessary for a market authorisation (required under the Veterinary Medicines Regulations) for the use of BCG in cattle and to achieve EU accreditation of the associated DIVA test. Experimental efficacy and safety studies for BCG have already been completed. Additional funding over the next three years will enable us to continue developing DIVA tests, evaluate the duration of sensitisation of cattle to the tuberculin skin test and conduct BCG field safety trials.
In addition to the science, wider acceptability, practicality, trade and legal issues impact the timing of the delivery of a licensed product. We have initiated discussions and will be working closely with the Commission and other member states to minimise the time required to make the necessary changes to allow the use of cattle vaccines for TB and to get the DIVA test integrated into the trade legislation. At this stage it is not possible to say how long these negotiations will take and success cannot be guaranteed.
Lord Taylor of Holbeach asked Her Majestys Government:
Further to the reply by Lord Rooker on 7 July (Official Report, col. 573), why the earliest projected date for widespread use of a badger vaccine is 2014, in the light of the time taken to develop the vaccine against bluetongue. [HL4882]
Lord Rooker: The earliest a fully licensed injectable vaccine could be available is projected as 2010. However, due to the costs associated with trapping badgers for vaccination, it is not likely to be used on a widespread basis.
The earliest projected date for the widespread use of a BCG oral badger vaccine is 2014. The oral vaccination route is not supported by a proven technology for delivery of BCG, and the difficulties of ensuring that the live vaccine can survive passing through the stomach and be adequately absorbed by the intestines make developing it a much more complex task than the injectable BCG vaccine. Scientific research by its nature takes time. While the programme of research has been designed to minimise the time required to deliver licensed vaccines, a significant proportion of the work can be addressed only sequentially. For example, the majority of safety and efficacy studies required for licensing an oral badger vaccine must use the final formulation and therefore cannot start until this is available. Additional funding will not result in a vaccine being available sooner but will allow further effort to be focused on addressing areas of scientific and policy uncertainty in an attempt to prevent the timeline from slipping. As with all research, there can be no guarantee of success.
Development of a vaccine against bovine TB, the causative agent of which is the bacterium Mycobacterium bovis, in badgers is fundamentally different and cannot be compared to the development of the vaccine against the bluetongue virus.
Lord Taylor of Holbeach asked Her Majesty's Government:
How long it will take to change the European Union rules against vaccinating cattle for tuberculosis once the United Kingdom makes an application following the successful development of a vaccine. [HL4884]
Lord Rooker: We have initiated discussions and will be working closely with the Commission and other member states to minimise the time required to make the necessary legislative changes to allow the use of cattle vaccines for TB. At this stage it is not possible to say how long negotiations will take.
Lord Thomas of Gresford asked Her Majestys Government:
Whether they will publish in the Official Report the letter about their proposals on the future of the Pensions Appeal Tribunal sent by Sir Robert Carnwath of the tribunals judiciary to Lord Morris of Manchester on 20 June and the response sent to Sir Robert by the Royal British Legion on 1 July. [HL4951]
The Parliamentary Under-Secretary of State, Ministry of Justice (Lord Hunt of Kings Heath): We will write to Lord Morris of Manchester and the Royal British
29 Sep 2008 : Column WA292
Lord Taylor of Holbeach asked Her Majestys Government:
Whether the Department for Environment, Food and Rural Affairs will exclude from its awards of grants from the bio-energy infrastructure scheme any applications which use (a) food crops, or (b) alternative crops grown on land suitable for food crops. [HL4946]
The Minister of State, Department for Environment, Food and Rural Affairs (Lord Rooker): With the exception of straw, biomass derived from food crops is not eligible for support under the scheme. Eligible energy crops are not required to be grown on land that is unsuitable for food crops. Of the 29 projects supported under round 1 of the scheme, 15 use only biomass from woodlands, urban trees and sawmills, seven use only purpose-grown energy crops and the remainder use a mixture.
Lord Taylor of Holbeach asked Her Majestys Government:
Further to the Statement by Lord Rooker on 7 July (Official Report, cols. 568-70), whether there has been any scientific investigation of the increase in the incidence of bovine tuberculosis following the 2001 outbreak of foot and mouth disease; and, if so, what was the outcome. [HL4885]
The Minister of State, Department for Environment, Food and Rural Affairs (Lord Rooker): Defra project SE3026, Bovine TB Transmission in Restocked Herds: Risk Factors and Dynamics, took advantage of the depopulation caused by the 2001 foot and mouth disease (FMD) outbreak and the need to restock herds following the epidemic to consider and identify risk factors associated with the introduction and transmission of bovine tuberculosis. This work was completed in 2006. While restocked herds appeared to be at risk immediately after FMD, both restocked and non-stocked herds had similar bovine tuberculosis incidence during the whole study. The significant associations between herd breakdowns and farm management practices were: purchasing steers, purchasing cattle from markets (versus private sales), increasing herd size, storage of manure in enclosed places compared with storing in the open or spreading immediately, and not feeding supplementary minerals and vitamins. The final report is available on the Defra website.
Additionally, an in-depth outbreak investigation by the Veterinary Laboratories Agency into a series of 31 cattle herds that suffered confirmed bovine tuberculosis incidents in the north-east of England between January
29 Sep 2008 : Column WA293
The Independent Scientific Group on Cattle TB (ISG) used the nine-month suspension of tuberculosis cattle controls during the 2001 nationwide epidemic of FMD as an opportunity to further evaluate the link between M. bovis infections in cattle and badgers. It found a significant association between the suspension of cattle tuberculosis controls and an increase in the prevalence of M. bovis infection in adult badgers. This rise was observed consistently across all seven proactively culled trial areas. A similar pattern was observed in road-killed badgers, which suggests that the effect was not driven by culling itself. While these observational data do not demonstrate causality, they provide evidence that cattle-to-badger transmission may be an important factor in bovine tuberculosis dynamics. Results are presented in the ISGs final report, available on the Defra website, and have been published in peer-reviewed scientific journals.
Lord Hanningfield asked Her Majestys Government:
How many farmers were overpaid or underpaid by the single farm payment scheme in each of the last three years in (a) England, (b) the east of England, and (c) Essex. [HL4979]
The Minister of State, Department for Environment, Food and Rural Affairs (Lord Rooker): The number of farmers that were overpaid under the single payment scheme (SPS) in England was 11,454 in 2005 and 7,493 in 2006. Figures are not yet available for the 2007 scheme year.
Detailed analysis of all payments made under SPS is not yet available and so it is not possible to give figures for the east of England and Essex. Once the remaining scheme payments have been completed, a decision will be taken on the level of detail that will be published.
The Rural Payments Agency (RPA) does not keep separate data on cases where a top-up payment was required after an SPS claim had been corrected, nor can such data now be readily identified. The RPA retains data on changes in claim values but there is no automatic relationship between these and underpayment data because manual or partial payment may have been made to the claimant.
Lord Taylor of Holbeach asked Her Majestys Government:
Further to the Written Statements by the Parliamentary Under-Secretary of State for Marine, Landscape and Rural Affairs, Mr Jonathan Shaw, on 16 June (Official Report, Commons, cols. 38-9WS), why the two organisations customer satisfaction
29 Sep 2008 : Column WA294
The Minister of State, Department for Environment, Food and Rural Affairs (Lord Rooker): The measurement of customer satisfaction varies according to the nature of the organisation, its objectives and its customer base. A common scale, with the same criteria, might restrict this flexibility.
The mechanism used by each agency is agreed individually with Defra and improving customer satisfaction is a performance management priority for all the departments agencies.
Lord Taylor of Holbeach asked Her Majestys Government:
Why the Dee Estuary Cockle Fishery Order (SI 2008/1472) contains no reference to offences under the Sea Fisheries (Shellfish) Act 1967 and the scale of penalties to be imposed, but the Explanatory Note to the order does; and [HL4950]
Whether the omission of any reference to offences and penalties in the Dee Estuary Cockle Fishery Order 2008 (SI 2008/1472) means that such penalties cannot be levied. [HL5005]
The Minister of State, Department for Environment, Food and Rural Affairs (Lord Rooker): Section 3(3) of the Sea Fisheries (Shellfish) Act 1967 states the offences and penalties that apply to the Dee Estuary Cockle Fishery Order 2008 (SI 2008/1472) (and other regulating orders). There is therefore no need to restate them in the order itself. Reference is made to Section 3(3) in the Explanatory Note to the Dee estuary order to guide the reader to the relevant offences and penalties provisions.
Lord Jenkin of Roding asked Her Majestys Government:
How much funding is being made available to assess the effectiveness and safety of new environmentally friendly, alternative flame retardants, which do not include the use of decaBDE. [HL4675]
The Minister of State, Department for Environment, Food and Rural Affairs (Lord Rooker): In 2003, the Environment Agency commissioned a report on the prioritisation of flame retardants for environmental risk assessment. The aim of the study was to assess the use of and risks associated with flame retardants, in particular to identify substances that might require detailed consideration in terms of their possible impact on the environment. It also considered issues concerning substitution of flame retardants. The study noted that little was known about the effects of many of the substances, including those sometimes proposed for use as environmentally friendly substitutes.
The new European regulation on the registration, evaluation, authorisation and restriction of chemicals (known as REACH) places on industry the responsibility to assess and understand the potential human health and environmental impacts of the substances that it produces in accordance with the principle of no data, no market. REACH also has the aim of replacing substances of very high concern, as defined by criteria in the regulation, with suitable alternatives. Industry will have to justify their continued use. These provisions will drive substitution of harmful substances and provide the assurance that the substitutes are less harmful than the substances that they replace. On current evidence, decabromodiphenyl ether (decaBDE) does not meet the criteria of a substance of very high concern.
Lord Jones of Cheltenham asked Her Majestys Government:
What assessment they have made of the environmental safety of decabromodiphenyl ether in (a) medical devices and (b) textiles. [HL4970]
Lord Rooker: HM Government prepared a detailed environmental risk assessment and two addenda on behalf of the European Commission under the existing substances regulation (EC No. 793/93). The most recent of these is dated October 2007. These reports assess the potential risks arising from all known uses of the substance, including its use in polymers (some of which are used in electrical equipment) and textiles. Medical devices have not been explicitly assessed but would be expected to be covered generically by the assessment of polymer use.
| Next Section | Back to Table of Contents | Lords Hansard Home Page |